Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%
Clinical trial NCT01695668 · COMPLETED
Trial details
- NCT number
- NCT01695668
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2013-09-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.